OraVescent Fentanyl

DRUG2 trials

Sponsors

Cephalon

Conditions

Diabetic NeuropathiesLow Back PainMigraineOsteoarthritisPain

Phase 3

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

CompletedNCT00228605

CephalonDiabetic Neuropathies, Low Back Pain, Migraine +1

Start: 2005-03-31End: 2007-05-31Target: 500Updated: 2014-05-09

Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

CompletedNCT00343733

Start: 2006-08-31End: 2007-07-31Target: 120Updated: 2014-05-09